The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...
It hasn’t been a smooth year for the two pharma giants, but events in the fourth quarter widened the gap between them.
Mike Plante struggled with his weight for years, but within six months of starting with the injection drug semaglutide, a medication for diabetes that's also being used for weight-loss ... obstructive ...
The U.S. Food and Drug Administration (FDA) has approved Zepbound, a prescription weight-loss medication, as the first drug ...
Meanwhile, as the popularity of weight-loss drugs soared, 2024 saw some Floridians turn to ... approved by the U.S. Food and ...
Ozempic has gotten most of the name recognition associated with weight-loss drugs, it's not the only drug in this category ...
This time last year, people were still bickering about whether Novo Nordisk's Wegovy and Eli Lilly & Co.'s Zepbound represented a shortcut to losing weight or a medical breakthrough. But with reams of ...
The FDA has declared an end to the shortage of a popular obesity drug. The implications for consumers are complicated.
Mike Plante struggled with his weight for years, but within six months of starting with the injection drug semaglutide, a medication for diabetes that's also being used for weight-loss, he's down 65 ...
By aiding weight loss, Zepbound can improve symptoms of obstructive sleep apnea (OSA) in people with obesity — but CPAP ...
GLP-1 receptor agonist weight loss drugs can negatively interact with eating disorder psychopathology and treatment in ...
Proposed federal dietary recommendations may bring new focus to what it means to eat healthy in 2025, but longstanding ...